This result resembles the efficacy of anti-CSF-1R treatment in combination with other ITs, e.g., while anti-CSF-1R was inefficient as a monotherapy, it supported the anti-tumor effect of the anti-CD40 monoclonal antibody in murine colon tumor models [25]. This evidence concerns the gene CSF1R and colonic neoplasm.